MX2007006138A - Nuevos compuestos. - Google Patents

Nuevos compuestos.

Info

Publication number
MX2007006138A
MX2007006138A MX2007006138A MX2007006138A MX2007006138A MX 2007006138 A MX2007006138 A MX 2007006138A MX 2007006138 A MX2007006138 A MX 2007006138A MX 2007006138 A MX2007006138 A MX 2007006138A MX 2007006138 A MX2007006138 A MX 2007006138A
Authority
MX
Mexico
Prior art keywords
rrol
chloro
benzamide
pain
compound according
Prior art date
Application number
MX2007006138A
Other languages
English (en)
Spanish (es)
Inventor
Paul Vincent Fish
Thomas Ryckmans
Alan Stobie
Florian Wakenhut
Gavin Alistair Whitlock
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2007006138A publication Critical patent/MX2007006138A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MX2007006138A 2004-11-23 2005-11-18 Nuevos compuestos. MX2007006138A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds
PCT/IB2005/003643 WO2006056884A1 (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors

Publications (1)

Publication Number Publication Date
MX2007006138A true MX2007006138A (es) 2007-07-19

Family

ID=33548739

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007006138A MX2007006138A (es) 2004-11-23 2005-11-18 Nuevos compuestos.

Country Status (26)

Country Link
EP (1) EP1817281A1 (ja)
JP (1) JP4233596B2 (ja)
KR (1) KR100886294B1 (ja)
CN (1) CN101065355A (ja)
AP (1) AP2007004003A0 (ja)
AR (1) AR052243A1 (ja)
AU (1) AU2005308534A1 (ja)
BR (1) BRPI0518486A2 (ja)
CA (1) CA2589258A1 (ja)
CR (1) CR9171A (ja)
EA (1) EA011217B1 (ja)
GB (1) GB0425766D0 (ja)
GT (1) GT200500337A (ja)
IL (1) IL183191A0 (ja)
MA (1) MA29038B1 (ja)
MX (1) MX2007006138A (ja)
NL (2) NL1030485C2 (ja)
NO (1) NO20072486L (ja)
PA (1) PA8653501A1 (ja)
PE (1) PE20061056A1 (ja)
SV (1) SV2006002311A (ja)
TN (1) TNSN07201A1 (ja)
TW (1) TWI300776B (ja)
UY (1) UY29224A1 (ja)
WO (1) WO2006056884A1 (ja)
ZA (1) ZA200703910B (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
MXPA05013960A (es) * 2003-06-17 2006-02-24 Pfizer Nuevos compuestos.

Also Published As

Publication number Publication date
NL1032760C2 (nl) 2007-04-17
IL183191A0 (en) 2007-08-19
GT200500337A (es) 2006-06-13
NL1030485A1 (nl) 2006-05-24
ZA200703910B (en) 2008-09-25
AP2007004003A0 (en) 2007-06-30
TNSN07201A1 (fr) 2008-11-21
EA200700920A1 (ru) 2007-12-28
NO20072486L (no) 2007-06-20
TW200626543A (en) 2006-08-01
BRPI0518486A2 (pt) 2008-11-18
NL1032760A1 (nl) 2006-12-13
EA011217B1 (ru) 2009-02-27
SV2006002311A (es) 2006-09-14
CA2589258A1 (en) 2006-06-01
AU2005308534A1 (en) 2006-06-01
NL1030485C2 (nl) 2006-11-07
KR100886294B1 (ko) 2009-03-04
AR052243A1 (es) 2007-03-07
PE20061056A1 (es) 2006-11-08
WO2006056884A1 (en) 2006-06-01
EP1817281A1 (en) 2007-08-15
CR9171A (es) 2007-07-04
PA8653501A1 (es) 2006-06-02
MA29038B1 (fr) 2007-11-01
TWI300776B (en) 2008-09-11
CN101065355A (zh) 2007-10-31
KR20070086599A (ko) 2007-08-27
UY29224A1 (es) 2006-06-30
GB0425766D0 (en) 2004-12-22
JP4233596B2 (ja) 2009-03-04
JP2008520646A (ja) 2008-06-19

Similar Documents

Publication Publication Date Title
US7122683B2 (en) Amides useful as monoamine re-uptake inhibitors
NL1026438C2 (nl) Nieuwe verbindingen.
AU2005266090A1 (en) Pyridine derivatives
KR20090092832A (ko) 비만, 제 ⅱ 형 당뇨병 및 ｃｎｓ 장애의 치료를 위한 신규한 아릴술폰아미드 화합물
BRPI0619126A2 (pt) derivados espirocìclicos, composição farmacêutica e usos dos mesmos
WO2007125398A2 (en) : sulfonamide compounds as antagonists of the n-type calcium channel
JP4157158B2 (ja) ドーパミン作動薬の新規な塩の形態
WO2007057775A1 (en) Spiropiperidine derivatives
CA2591415A1 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
US20090239928A1 (en) N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
MX2007006138A (es) Nuevos compuestos.
US20090239929A1 (en) N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
JP2007517855A (ja) セロトニン及びノルアドレナリン再取込み阻害剤としての活性を示すピペラジン誘導体
WO2007135530A2 (en) Pharmaceutically & veterinarily suitable salt
MXPA06008019A (en) Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-upatke inhibitors

Legal Events

Date Code Title Description
FG Grant or registration